82.00
+1.00
+(1.23%)
At close: January 30 at 7:31:04 PM GMT+1
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
118,218,000.00
108,908,000.00
78,887,000.00
55,000,000.00
51,951,000.00
Investing Cash Flow
-52,396,000.00
-43,892,000.00
-24,918,000.00
-31,605,000.00
-22,436,000.00
Financing Cash Flow
-38,216,000.00
-63,158,000.00
-51,797,000.00
-25,493,000.00
-32,244,000.00
End Cash Position
57,489,000.00
14,392,000.00
12,653,000.00
10,719,000.00
12,226,000.00
Capital Expenditure
-51,187,000.00
-38,896,000.00
-14,753,000.00
-7,385,000.00
-22,081,000.00
Issuance of Debt
34,632,000.00
--
11,215,000.00
22,160,000.00
5,682,000.00
Repayment of Debt
-6,257,000.00
-1,467,000.00
-13,623,000.00
-6,689,000.00
-950,000.00
Repurchase of Capital Stock
-22,451,000.00
-29,924,000.00
-24,086,000.00
-19,447,000.00
-16,855,000.00
Free Cash Flow
67,031,000.00
70,012,000.00
64,134,000.00
47,615,000.00
29,870,000.00
12/31/2020 - 3/25/2020
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
0QYQ.IL Gilead Sciences, Inc.
96.12
+0.42%
4568.T Daiichi Sankyo Company, Limited
4,412.00
+0.39%
SNY Sanofi
54.15
+3.84%
ROG.SW Roche Holding AG
285.20
+1.57%
NVS Novartis AG
104.75
+1.77%
LLY Eli Lilly and Company
823.23
+2.38%
AMGN Amgen Inc.
284.02
+0.83%
JNJ Johnson & Johnson
152.87
+1.14%
PFE Pfizer Inc.
26.91
+1.09%
ABBV AbbVie Inc.
175.65
+0.22%